Arthritis: all 3,555 studies

Page 6 of 36. Open to participants first (313), then studies with results posted, then the rest; newest registration first within each.

• A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)CompletedNCT02814175Phase 4Results posted
• Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily RoutineCompletedNCT02809833Results posted
• Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)CompletedNCT02808871Phase 2Results posted
• Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid ArthritisCompletedNCT02799472Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to PlaceboCompletedNCT02798211Phase 4Results posted
• Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to RituximabCompletedNCT02792699Phase 3Results posted
• Safety and Efficacy Study of M2951 in Participants With Rheumatoid ArthritisCompletedNCT02784106Phase 2Results posted
• A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid ArthritisCompletedNCT02780388Phase 1Results posted
• An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)CompletedNCT02776735Phase 2Results posted
• Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon SiteCompletedNCT02771210Phase 3Results posted
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active DiseaseCompletedNCT02760433Phase 3Results posted
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseaseCompletedNCT02760407Phase 3Results posted
• Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseaseCompletedNCT02760368Phase 3Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• MTX Discontinuation and Vaccine ResponseCompletedNCT02748785Phase 4Results posted
• The Assessment of Patient Specific Instrumentation for Unicompartmental Knee ReplacementCompletedNCT02748096Not applicableResults posted
• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic ArthritisCompletedNCT02745080Phase 3Results posted
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid ArthritisCompletedNCT02744755Phase 3Results posted
• Usability of an AI for M923 in Subjects With Moderate to Severe RACompletedNCT02722044Phase 3Results posted
• Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton InvolvementCompletedNCT02721966Phase 3Results posted
• A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDsCompletedNCT02720523Phase 2/3Results posted
• BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic ArthritisCompletedNCT02719171Phase 2Results posted
• A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)CompletedNCT02706951Phase 3Results posted
• A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateCompletedNCT02706873Phase 3Results posted
• A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsCompletedNCT02706847Phase 3Results posted
• Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid ArthritisCompletedNCT02699892Results posted
• Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT ImagingCompletedNCT02683421Phase 1Results posted
• Tocilizumab Real-Life Human Factors (RLHFs) Validation StudyCompletedNCT02682823Phase 4Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs AloneCompletedNCT02675426Phase 3Results posted
• Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in ChinaCompletedNCT02668640Results posted
• Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT02662985Phase 3Results posted
• Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid ArthritisTerminatedNCT02659150Phase 4Results posted
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisCompletedNCT02640612Phase 3Results posted
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT02638948Phase 2Results posted
• Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid ArthritisCompletedNCT02638259Phase 3Results posted
• Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled SyringeCompletedNCT02636907Phase 2Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to MethotrexateActive, not recruitingNCT02629159Phase 3Results posted
• Real-World Outcome of Rheumatoid Arthritis Patients in Korea on AdalimumabCompletedNCT02627924Results posted
• Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)CompletedNCT02626026Phase 1Results posted
• Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in TaiwanCompletedNCT02616380Results posted
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeCompletedNCT02605642Results posted
• Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid ArthritisTerminatedNCT02603146Phase 2Results posted
• Start Time Optimization of Biologics in Polyarticular JIACompletedNCT02593006Results posted
• Efficacy Study Of Tofacitinib In Pediatric JIA PopulationCompletedNCT02592434Phase 3Results posted
• An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.CompletedNCT02590562Results posted
• SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee OsteoarthritisCompletedNCT02585323Not applicableResults posted
• The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis StudyCompletedNCT02585258Phase 4Results posted
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCompletedNCT02584855Phase 3Results posted
• Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis ParticipantsCompletedNCT02573012Phase 4Results posted
• An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid ArthritisCompletedNCT02565810Phase 2Results posted
• An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RATerminatedNCT02557295Results posted
• Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid ArthritisCompletedNCT02557100Phase 4Results posted
• OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory ArthritisCompletedNCT02554474Not applicableResults posted
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)CompletedNCT02538341Phase 2Results posted
• To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid ArthritisTerminatedNCT02534896Phase 3Results posted
• Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) StudyCompletedNCT02528786Phase 1Results posted
• Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate IntensityCompletedNCT02519387Phase 4Results posted
• An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisCompletedNCT02518620Phase 2Results posted
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®CompletedNCT02514772Phase 3Results posted
• A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.CompletedNCT02512575Phase 1Results posted
• An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With RituximabCompletedNCT02507752Results posted
• Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid ArthritisCompletedNCT02504671Phase 2Results posted
• Effects of Abatacept in Patients With Early Rheumatoid ArthritisCompletedNCT02504268Phase 3Results posted
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
• Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) ParticipantsCompletedNCT02485483Results posted
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).CompletedNCT02480153Phase 3Results posted
• Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid ArthritisCompletedNCT02467504Phase 2Results posted
• An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)CompletedNCT02451839Results posted
• IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedNCT02451748Phase 4Results posted
• Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 StudyCompletedNCT02433340Phase 2Results posted
• Abatacept for SLE Arthritis (IM101-330)TerminatedNCT02429934Phase 1/2Results posted
• Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])CompletedNCT02414633Results posted
• Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint ProsthesisTerminatedNCT02408471Not applicableResults posted
• A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis PatientsCompletedNCT02405780Phase 3Results posted
• A Multi-center Outcomes Clinical Study of the PyroTITAN™ HRA Shoulder Implant in Humeral Head ResurfacingCompletedNCT02405208Results posted
• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic ArthritisCompletedNCT02404350Phase 3Results posted
• Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIACompletedNCT02396212Phase 3Results posted
• Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to MethotrexateTerminatedNCT02393378Phase 2Results posted
• ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background MethotrexateCompletedNCT02387762Phase 2Results posted
• Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT02379091Phase 2Results posted
• Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis SubjectsCompletedNCT02378506Phase 3Results posted
• Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisCompletedNCT02376790Phase 3Results posted
• Treatments Against RA and Effect on FDG-PET/CTCompletedNCT02374021Phase 4Results posted
• Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionCompletedNCT02373813Phase 3Results posted
• A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)CompletedNCT02373202Phase 3Results posted
• Efficacy Study of Dextromethorphan to Treat Rheumatoid ArthritisCompletedNCT02368093Not applicableResults posted
• Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or AbataceptTerminatedNCT02353780Phase 4Results posted
• Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.CompletedNCT02350881Results posted
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCompletedNCT02349295Phase 3Results posted
• A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 StudiesCompletedNCT02334748Phase 3Results posted
• Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)CompletedNCT02332590Phase 3Results posted
• 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)TerminatedNCT02328027Phase 1/2Results posted
• Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis PatientsCompletedNCT02321930Phase 4Results posted
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)CompletedNCT02319759Phase 2Results posted
• An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044CompletedNCT02319642Phase 3Results posted
• A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisCompletedNCT02309359Phase 2Results posted
• A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDsCompletedNCT02308163Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) TreatmentCompletedNCT02305849Phase 3Results posted
• Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT02296775Phase 1/2Results posted
• ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of CanakinumabCompletedNCT02296424Phase 3Results posted

← Arthritis overview